Giuseppe Tonini

Giuseppe Tonini

Università Campus Bio Medico di Roma - Rome / Italy
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 1807321
Campus Bio-Medico University of Rome
person_outline Giuseppe Tonini's MOST POPULAR ARTICLES
1-) FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular … The Lancet Oncology 16 (13), 1306-1315, 2015
2-) Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer New England Journal of Medicine 371 (17), 1609-1618, 2014
3-) Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr) Journal of endocrinological investigation 29, 581-593, 2006
4-) KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer British journal of cancer 101 (4), 715-721, 2009
5-) KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancerF Loupakis, A Ruzzo, C Cremolini, B Vincenzi, L Salvatore, D Santini, ...British journal of cancer 101 (4), 715-721, 20097202009